Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic

PURPOSE: Physician treatment preferences for early stage, estrogen positive breast cancer (ER + BC) patients were evaluated during the initial surge of the COVID-19 pandemic in the US when neoadjuvant endocrine therapy (NET) was recommended to allow safe deferral of surgery. METHODS: A validated ele...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer Res Treat
Hlavní autoři: Park, Ko Un, Gregory, Megan, Bazan, Joey, Lustberg, Maryam, Rosenberg, Shoshana, Blinder, Victoria, Sharma, Priyanka, Pusztai, Lajos, Shen, Chengli, Partridge, Ann, Thompson, Alastair
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer US 2021
Témata:
Epidemiology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7921279/
https://ncbi.nlm.nih.gov/pubmed/33651271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-021-06153-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky